The Institute for Myeloma and Bone Cancer Research is a extremely helpful organization. Under the knowledgeable hand of Dr. James Berenson, the institute conducts ground-breaking research on new drugs and drug combinations, understanding the complex mechanisms involved in the myeloma progression and developing therapies that are tailored to the genetic profile of myeloma patients. Moreover, the institute has a large outreach function, producing informational videos and media interviews that relate important information to myeloma patients around the world. The Institute for Myeloma and Bone Cancer Research is a vital platform to help research and treat this difficult disease while improving the quality of life of myeloma patients everywhere.